This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
This piece explains the meaning of nonce in blockchain, its role in securing proofs of work, and how it prevents duplicate blocks.
14,082 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Pope Leo XIV releases Magnifica Humanitas, an AI-focused encyclical urging human-centered tech and fair wages, igniti...
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...
After a staggering 453% surge, investors face a crossroads: take profits now or double down on a company reshaping th...
Investors eye AGNC for a high yield, but sustainability is key. This analysis breaks down how AGNC funds its dividend...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A chief revenue officer at a growing restaurant-tech company recently sold a sizable block of stock. Insider moves li...